Skip to main content
Top
Published in: BMC Health Services Research 1/2010

Open Access 01-12-2010 | Research article

Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia

Authors: Anna L Ridge, Lisa A Bero, Suzanne R Hill

Published in: BMC Health Services Research | Issue 1/2010

Login to get access

Abstract

Background

Pre-eclampsia and eclampsia are serious complications of pregnancy and major causes of maternal mortality and morbidity worldwide. According to systematic reviews and WHO guidelines magnesium sulphate injection (MgSO4) should be the first -line treatment for severe pre-eclampsia and eclampsia. Studies have shown that this safe and effective medicine is unavailable and underutilized in many resource poor countries. The objective of this study was to identify barriers to the availability and use of MgSO4 in the Zambian Public Health System.

Methods

A 'fishbone' (Ishikawa) diagram listing probable facilitators to the availability and use of MgSO4 identified from the literature was used to develop an assessment tool. Barriers to availability and use of MgSO4 were assessed at the regulatory/government, supply, procurement, distribution, health facility and health professional levels. The assessment was completed during August 2008 using archival data, and observations at a pragmatic sample of health facilities providing obstetric services in Lusaka District, Zambia.

Results

The major barrier to the availability of MgSO4 within the public health system in Zambia was lack of procurement by the Ministry of Health. Other barriers identified included a lack of demand by health professionals at the health centre level and a lack of in-service training in the use of MgSO4. Where there was demand by obstetricians, magnesium sulphate injection was being procured from the private sector by the hospital pharmacy despite not being registered and licensed for use for the treatment of severe pre-eclampsia and eclampsia by the national Pharmaceutical Regulatory Authority.

Conclusions

The case study in Zambia highlights the complexities that underlie making essential medicines available and used appropriately. The fishbone diagram is a useful theoretical framework for illustrating the complexity of translating research findings into clinical practice. A better understanding of the supply system and of the pattern of demand for MgSO4 in Zambia should enable policy makers and stakeholders to develop and implement appropriate interventions to improve the availability and use of MgSO4.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: The World Health Report 2005: Make every mother and child count. 2005, Geneva: World Health Organization, --- Either first page or author must be supplied..CrossRef World Health Organization: The World Health Report 2005: Make every mother and child count. 2005, Geneva: World Health Organization, --- Either first page or author must be supplied..CrossRef
2.
go back to reference Dolea C, AbouZahr C: Global burden of hypertensive disorders of pregnancy in the year 2000. Global Burden of Diseases 2000 Working Paper. 2003, Geneva: World Health Organization Dolea C, AbouZahr C: Global burden of hypertensive disorders of pregnancy in the year 2000. Global Burden of Diseases 2000 Working Paper. 2003, Geneva: World Health Organization
3.
go back to reference Duley L, Gulmezoglu AM: Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database of Systematic Reviews. 2000, CD002960-3 Duley L, Gulmezoglu AM: Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database of Systematic Reviews. 2000, CD002960-3
4.
go back to reference Duley L, Henderson-Smart DJ: Magnesium sulphate versus diazepam for eclampsia. Cochrane Database of Systematic Reviews. 2003, CD000127-4 Duley L, Henderson-Smart DJ: Magnesium sulphate versus diazepam for eclampsia. Cochrane Database of Systematic Reviews. 2003, CD000127-4
5.
go back to reference Duley L, Henderson-Smart DJ: Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews. 2003, CD000128-4 Duley L, Henderson-Smart DJ: Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews. 2003, CD000128-4
6.
go back to reference Duley L, Gülmezoglu AM, Henderson-Smart DJ: Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews. 2003, CD000125-4 Duley L, Gülmezoglu AM, Henderson-Smart DJ: Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews. 2003, CD000125-4
8.
go back to reference Sevene E, Lewin S, Mariano A, Woelk G, Oxman AD, Matinhure S, Cliff J, Fernandes B, Daniels K: System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ. 2005, 331: 765-769. 10.1136/bmj.331.7519.765.CrossRefPubMedPubMedCentral Sevene E, Lewin S, Mariano A, Woelk G, Oxman AD, Matinhure S, Cliff J, Fernandes B, Daniels K: System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ. 2005, 331: 765-769. 10.1136/bmj.331.7519.765.CrossRefPubMedPubMedCentral
9.
go back to reference Aaserud M, Lewin S, Innvar S, Paulsen EJ, Dahlgren AT, Trommald M, Duley L, Zwarenstein M, Oxman A: Translating research into policy in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Services Research. 2005, 5: 68-10.1186/1472-6963-5-68.CrossRefPubMedPubMedCentral Aaserud M, Lewin S, Innvar S, Paulsen EJ, Dahlgren AT, Trommald M, Duley L, Zwarenstein M, Oxman A: Translating research into policy in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Services Research. 2005, 5: 68-10.1186/1472-6963-5-68.CrossRefPubMedPubMedCentral
10.
go back to reference Flottorp S, Oxman A: Identifying barriers and tailoring interventions to improve the management of urinary tract infections and sore throat: a pragmatic study using qualitative methods. BMC Health Services Research. 2003, 3: 3-10.1186/1472-6963-3-3.CrossRefPubMedPubMedCentral Flottorp S, Oxman A: Identifying barriers and tailoring interventions to improve the management of urinary tract infections and sore throat: a pragmatic study using qualitative methods. BMC Health Services Research. 2003, 3: 3-10.1186/1472-6963-3-3.CrossRefPubMedPubMedCentral
12.
go back to reference Disha A, Bwembya M, Collins E, Papworth D, Ronnow E: Zambia: family planning quantitative and qualitative logistic system assessment. 2008, USAID/DELIVER PROJECT, Task Order 1.USA: Arlington, Virginia Disha A, Bwembya M, Collins E, Papworth D, Ronnow E: Zambia: family planning quantitative and qualitative logistic system assessment. 2008, USAID/DELIVER PROJECT, Task Order 1.USA: Arlington, Virginia
13.
go back to reference Grol R, Wensing M, Eccles M: Improving patient care. The implementation of change in clinical practice. 2005, United Kingdom: Elsevier Limited Grol R, Wensing M, Eccles M: Improving patient care. The implementation of change in clinical practice. 2005, United Kingdom: Elsevier Limited
14.
go back to reference Hartnell N, MacKinnon NJ, Jones EJM, Genge R, Nestel MDM: Perceptions of patients and health care professionals about factors contributing to medication errors and potential areas for improvement. Canadian Journal of Hospital Pharmacy. 2006, 59 (4): 177-83. Hartnell N, MacKinnon NJ, Jones EJM, Genge R, Nestel MDM: Perceptions of patients and health care professionals about factors contributing to medication errors and potential areas for improvement. Canadian Journal of Hospital Pharmacy. 2006, 59 (4): 177-83.
15.
go back to reference World Health Organization: Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice. 2006, Geneva: World Health Organization, --- Either first page or author must be supplied.. 2 World Health Organization: Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice. 2006, Geneva: World Health Organization, --- Either first page or author must be supplied.. 2
16.
go back to reference World Health Organization: Managing complications in pregnancy and childbirth: a guide for midwives and doctors. 2007, Geneva: World Health Organization, 2 World Health Organization: Managing complications in pregnancy and childbirth: a guide for midwives and doctors. 2007, Geneva: World Health Organization, 2
17.
go back to reference World Health Organization: The Rational Use of Drugs. Report of the Conference of Experts 1985. 1987, Geneva: WHO, --- Either first page or author must be supplied.. World Health Organization: The Rational Use of Drugs. Report of the Conference of Experts 1985. 1987, Geneva: WHO, --- Either first page or author must be supplied..
18.
go back to reference Tita ATN, Selwyn BJ, Waller DK, Kapadia AS, Dongmo S: Evidence-based reproductive health care in Cameroon: population-based study of awareness, use and barriers. Bulletin of the World Health Organization. 2005, 83: 895-903.PubMed Tita ATN, Selwyn BJ, Waller DK, Kapadia AS, Dongmo S: Evidence-based reproductive health care in Cameroon: population-based study of awareness, use and barriers. Bulletin of the World Health Organization. 2005, 83: 895-903.PubMed
19.
go back to reference Management Sciences for Health in collaboration with the World Health Organization: Managing Drug Supply. 1997, USA: Kumarian Press, --- Either first page or author must be supplied.. Management Sciences for Health in collaboration with the World Health Organization: Managing Drug Supply. 1997, USA: Kumarian Press, --- Either first page or author must be supplied..
20.
go back to reference Frost LJ, Reich MR: Access: How do good health technologies get to poor people in poor countries?. 2008, USA: Harvard University Press Frost LJ, Reich MR: Access: How do good health technologies get to poor people in poor countries?. 2008, USA: Harvard University Press
21.
go back to reference Daniels K, Lewin S, the Practihc Policy Group (ppg): Translating research into maternal health care policy: a qualitative case study of the use of evidence in policies for the treatment of eclampsia and pre-eclampsia in South Africa. Health Research Policy and Systems. 2008, 6: 12-10.1186/1478-4505-6-12.CrossRefPubMedPubMedCentral Daniels K, Lewin S, the Practihc Policy Group (ppg): Translating research into maternal health care policy: a qualitative case study of the use of evidence in policies for the treatment of eclampsia and pre-eclampsia in South Africa. Health Research Policy and Systems. 2008, 6: 12-10.1186/1478-4505-6-12.CrossRefPubMedPubMedCentral
22.
go back to reference Albert AM, Fretheim A, Maïga D: Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines. Health Research Policy and Systems. 2007, 5: 2-10.1186/1478-4505-5-2.CrossRefPubMedPubMedCentral Albert AM, Fretheim A, Maïga D: Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines. Health Research Policy and Systems. 2007, 5: 2-10.1186/1478-4505-5-2.CrossRefPubMedPubMedCentral
Metadata
Title
Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
Authors
Anna L Ridge
Lisa A Bero
Suzanne R Hill
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2010
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-10-340

Other articles of this Issue 1/2010

BMC Health Services Research 1/2010 Go to the issue